Single Dose Study to Assess the Safety, Tolerability, Concentration in Body and Effect of BAF312
Clinical trial NCT00422175 · COMPLETED
Trial details
- NCT number
- NCT00422175
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.